STAT+: Pharmalittle: Curevac loses key patent in battle with BioNTech; Abernethy to step down as Verily CMO
A German court invalidated a patent at the center of a CureVac lawsuit against BioNTech, in a blow to CureVac's claim for Covid vaccine revenues.
by Ed Silverman
Dec 20, 2023
1 minute
Good morning, everyone, and how are you today? We are doing just fine, thank you. Given that this is already the middle of the week and we have survived this far, no reason
You’re reading a preview, subscribe to read more.
Start your free 30 days